China Traditional Chinese Medicine Holdings Co (CHIZF) AI Stock Analysis

8 Followers

China Traditional Chinese Medicine Holdings Co

(Other OTC:CHIZF)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Low leverage and financial flexibilityFalling debt relative to equity gives the company greater financial flexibility over the next several quarters. Lower leverage reduces refinancing pressure and leaves more capacity to support operations, manage industry volatility, or fund selective investment without relying heavily on additional borrowing.

Negative Factors

Profitability deterioration and 2025 lossThe shift from sustained profits to a 2025 net loss is a material deterioration in earnings quality and reduces the company’s ability to compound shareholder value. Continued losses could constrain reinvestment and weaken the effectiveness of its otherwise conservative balance sheet.

China Traditional Chinese Medicine Holdings Co (CHIZF) vs. SPDR S&P 500 ETF (SPY)

Market Cap: $821.34M
Dividend Yield: 0.28%
Average Volume (3M): ―
Price to Earnings (P/E): -4.1
Beta (1Y): 0.33
Revenue Growth: -16.02%
EPS Growth: -297.26%
Country: US
Employees: 14,846
Sector: Healthcare
Sector Strength: 51
Industry: Drug Manufacturers - Specialty & Generic

China Traditional Chinese Medicine Holdings Co Business Overview & Revenue Model

Company Description

China Traditional Chinese Medicine Holdings Co. Limited functions as an investment holding company, primarily focusing on the research, development, and sale of traditional Chinese medicine and other pharmaceutical goods across the People's Republic...

China Traditional Chinese Medicine Holdings Co Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

CHIZF against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
HK:6896	65Neutral	HKD 1.42B	5.65	16.70%	17.99%	-5.37%	-18.03%
HK:0897	59Neutral	HKD 395.61M	102.78	0.34%	―	-8.30%	-44.44%
HK:0874	57Neutral	HKD 35.45B	14.67	5.57%	6.73%	6.00%	-23.05%
HK:0512	55Neutral	HKD 15.72B	13.63	6.61%	3.87%	7.35%	-45.49%
HK:0719	54Neutral	HKD 8.52B	38.30	4.32%	3.22%	-0.52%	-37.60%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

* Healthcare Sector Average

Performance Comparison

CHIZF and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
CHIZF	China Traditional Chinese Medicine Holdings Co	0.16	-0.11	-40.29%
HK:0874	Guangzhou Baiyunshan Pharmaceutical Holdings Company Class H	12.82	-6.27	-32.83%
HK:0897	Wai Yuen Tong Medicine Holdings Limited	0.37	-0.09	-19.57%
HK:0512	Grand Pharmaceutical Group Limited	4.37	-4.10	-48.38%
HK:6896	Golden Throat Holdings Group Co Ltd	1.89	-1.22	-39.25%
HK:0719	Shandong Xinhua Pharmaceutical Company Limited Class H	5.36	-1.65	-23.61%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

China Traditional Chinese Medicine Holdings Co AI Stock Analysis